Literature DB >> 18247154

Medication persistence among patients with asthma/COPD drugs.

Dan Haupt1, Kristin Krigsman, J Lars G Nilsson.   

Abstract

OBJECTIVE: To determine medication possession ratio (MPR) of patients with asthma/COPD drugs.
METHOD: Individual patient's volumes of asthma/COPD drugs (ATC-code R03) for 2000-2004 were obtained from a pharmacy record database. For each patient the MPR was calculated as the percentage of the treatment time that the patient had drugs available. MAIN OUTCOME MEASURE: Medication possession ratio (MPR).
RESULTS: A total of 1,812 patients, 20 years and older, with dispensed asthma/COPD drugs were registered in the database, 928 patients (51%) had acquired drugs less than once per year (68% for 20-29 years old) during the 5-year study. Only 13% of the patients had steroids and steroid combinations available to allow continuous treatment. Eight percent of the patients 20-29 years old had MPR > or = 80% of all the included drugs and 5% when only steroids and steroid combinations were considered. About 25% of the patients had acquired 80% of the total volume of asthma/COPD drugs.
CONCLUSION: The majority of the patients, and particularly those in the youngest age group used asthma/COPD drugs only sporadically. This may indicate undermedication which is likely to have a negative impact on patient outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247154     DOI: 10.1007/s11096-008-9197-4

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  20 in total

1.  Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.

Authors:  Marc Dorais; Lucie Blais; Isabelle Chabot; Jacques LeLorier
Journal:  J Asthma       Date:  2005-06       Impact factor: 2.515

Review 2.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

3.  Unawareness and undertreatment of asthma and allergic rhinitis in a general population.

Authors:  Hendrik Nolte; Steen Nepper-Christensen; Vibeke Backer
Journal:  Respir Med       Date:  2005-07-11       Impact factor: 3.415

4.  How often is the diagnosis bronchial asthma correct?

Authors:  B Marklund; A Tunsäter; C Bengtsson
Journal:  Fam Pract       Date:  1999-04       Impact factor: 2.267

5.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors:  B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

Review 6.  Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment.

Authors:  Stephen P Peters; Gary Ferguson; Yamo Deniz; Colin Reisner
Journal:  Respir Med       Date:  2006-05-18       Impact factor: 3.415

Review 7.  Interventions to enhance medication adherence.

Authors:  R B Haynes; X Yao; A Degani; S Kripalani; A Garg; H P McDonald
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

8.  Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.

Authors:  L Wei; J Wang; P Thompson; S Wong; A D Struthers; T M MacDonald
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

9.  Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization of data.

Authors:  A Wessling
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Underdiagnosis and undertreatment of COPD in primary care settings.

Authors:  Tsuneyuki Takahashi; Masakazu Ichinose; Hiroshi Inoue; Kunio Shirato; Toshio Hattori; Tamotsu Takishima
Journal:  Respirology       Date:  2003-12       Impact factor: 6.424

View more
  16 in total

1.  Factors affecting satisfaction with education program for chronic airway disease in primary care settings.

Authors:  Andrew Kim; Yong Il Hwang; Joo Hee Kim; Seung Hun Jang; Sunghoon Park; Ji Young Park; Ki-Suck Jung; Kwang Ha Yoo; Yong Bum Park; Hyoung Kyu Yoon; Chin Kook Rhee; Deog Kyeom Kim; Ho-Kee Yum
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Predictors of adherence to inhaled medications among Veterans with COPD.

Authors:  John C Huetsch; Jane E Uman; Edmunds M Udris; David H Au
Journal:  J Gen Intern Med       Date:  2012-07-11       Impact factor: 5.128

3.  Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease - A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA).

Authors:  Kani Khalaf; Sten Axelsson Fisk; Ann Ekberg-Jansson; George Leckie; Raquel Perez-Vicente; Juan Merlo
Journal:  Clin Epidemiol       Date:  2020-07-20       Impact factor: 4.790

4.  Regional variation and adherence to guidelines for drug treatment of asthma.

Authors:  Marianne Heibert Arnlind; Björn Wettermark; Mika Nokela; Paul Hjemdahl; Clas Rehnberg; Eva Wikström Jonsson
Journal:  Eur J Clin Pharmacol       Date:  2009-10-14       Impact factor: 2.953

5.  Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease.

Authors:  Masaya Takemura; Katsumi Mitsui; Ryo Itotani; Manabu Ishitoko; Shinko Suzuki; Masataka Matsumoto; Kensaku Aihara; Tsuyoshi Oguma; Tetsuya Ueda; Hitoshi Kagioka; Motonari Fukui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-20

Review 6.  Improving adherence with inhaler therapy in COPD.

Authors:  Suzanne C Lareau; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-11-24

Review 7.  Medication adherence issues in patients treated for COPD.

Authors:  Ruben D Restrepo; Melissa T Alvarez; Leonard D Wittnebel; Helen Sorenson; Richard Wettstein; David L Vines; Jennifer Sikkema-Ortiz; Donna D Gardner; Robert L Wilkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

8.  Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences.

Authors:  Shaonan Liu; Jiaqi Lai; Lei Wu; Xinfeng Guo
Journal:  Patient Prefer Adherence       Date:  2021-07-08       Impact factor: 2.711

9.  A novel model-based approach for dose determination of glycopyrronium bromide in COPD.

Authors:  Helen Arievich; Tim Overend; Didier Renard; Michael Gibbs; Vijay Alagappan; Michael Looby; Donald Banerji
Journal:  BMC Pulm Med       Date:  2012-12-08       Impact factor: 3.317

10.  Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients.

Authors:  Masaya Takemura; Katsumi Mitsui; Masako Ido; Masataka Matsumoto; Misuzu Koyama; Daiki Inoue; Kazufumi Takamatsu; Ryo Itotani; Manabu Ishitoko; Shinko Suzuki; Kensaku Aihara; Minoru Sakuramoto; Hitoshi Kagioka; Motonari Fukui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.